News

Imprime PGG is a novel immunomodulatory drug in development as a cancer therapy. The company expects to recruit around 795 patients in over 50 locations worldwide, including the

Dexamethasone elixir, a corticosteroid, is indicated for the treatment for variety of conditions including endocrine disorders, rheumatic disorders, and collagen diseases. Dexamethasone elixir works by decreasing or preventing

The acquisition will allow Takeda to add roflumilast franchise (Daxas; trade name in Europe), indicated as the treatment for chronic obstructive pulmonary disease (COPD), into its product portfolio

Levocetirizine Solution, 2.5 mg/5ml is the generic version of UCB’s Xyzal Oral Solution, indicated for the treatment of indoor and outdoor allergies. Synthon and UCB are currently engaged

CATS1 Phase I/II trial intends to investigate the tolerability and efficacy of Ovasave, a type 1 regulatory T cell based immunotherapy, in patients with severe chronic active Crohn’s

Medical Office Online is a 2011-2012 ONC-ATCB certified integrated solution which meets the requirements for meaningful use and is therefore eligible for funding through the federal government’s ARRA

Axitinib is an oral and selective inhibitor of vascular endothelial growth factor (VEGF) receptors 1, 2 and 3, receptors that can influence tumor growth, vascular angiogenesis and progression

Aquaprin, a liquid derivative of aspirin, is the US Food and Drug Administration approved over-the-counter (OTC) liquid pain reliever. PharmStar Pharmaceuticals claims the product is designed to dissolve

TCGRx claims MedPickRx not only reduces oral solid formulary prescription fill time upto 40%, but also eliminates shelving space with its high density storage capacity. The saved space